OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+38.74%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$217M
AUM Growth
–
Cap. Flow
+$217M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$82.5M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$74.4M |
| 3 |
FibroGen
FGEN
|
$26.6M |
| 4 |
EGLT
Egalet Corporation
EGLT
|
$15.1M |
| 5 |
AKAO
Achaogen, Inc.
AKAO
|
$8.57M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 58.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $82.5M | 37.93% | +2,138,872 | New | +$82.5M |
|
|
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
| $74.4M | 34.23% | +1,425,000 | New | +$74.4M |
|
|
3
FibroGen
FGEN
$47.8M
| $26.6M | 12.23% | +972,175 | New | +$26.6M |
|
|
EGLT
4
DELISTED
Egalet Corporation
EGLT
| $15.1M | 6.92% | +2,645,558 | New | +$15.1M |
|
|
AKAO
5
DELISTED
Achaogen, Inc.
AKAO
| $8.57M | 3.94% | +656,899 | New | +$8.57M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.72M | 3.55% | +468,471 | New | +$7.72M |
|
7
Protara Therapeutics
TARA
$120M
| $2.6M | 1.2% | +250,000 | New | +$2.6M |
|